Today we are talking about the famous RU 486.
Roussel Uclaf did not seekU.S. approval, so in the United States legal availability
was not initially possible. The United
States banned importation of mifepristone
for personal use in 1989, a
decision supported by Roussel Uclaf. In 1994, Roussel Uclaf gave the U.S.
drug rights to the Population Council in exchange for immunity from any product
liability claims. The Population Council sponsored clinical trials in the United States .
The drug went on approvable status from 1996.
Production was intended to begin through the Danco Group in 1996, but they withdrew briefly in 1997 due to a corrupt business partner, delaying availability again. Mifepristone was approved for abortion in theUnited
States by the FDA, in September 2000. It is
legal and available in all 50 states, Washington ,
D.C. , Guam, and Puerto
Rico . It is a prescription drug, but it is not available to the
public through pharmacies; its distribution is restricted to specially
qualified licensed physicians, sold by Danco Laboratories under the trade name
Mifeprex.
Roussel Uclaf did not seek
Production was intended to begin through the Danco Group in 1996, but they withdrew briefly in 1997 due to a corrupt business partner, delaying availability again. Mifepristone was approved for abortion in the
Medical abortions voluntarily reported by 33
U.S. states to the CDC have increased as a percentage of total abortions every
year sinc3 the approval of mifepristone: 1.0% in 2000, 2.9% in 2001, 5.2% in
2002, 7.9% in 2003, 9.3% in 2004, 9.9% in 2005, 10.6% in 2006, and 13.1% in
2007 (20.3% of those at less than 9 weeks gestation), AGuttmacher Institute survey of abortion
providers estimated that medical abortions accounted for 17% of all abortions
and slightly over 25% of abortions before 9 weeks gestation in the United States
in 2008 (94% of nonhospital medical abortions used mifepristone and
misoprostol, 6% used methotrexate and misoprostol). Medical abortions accounted
for 32% of first trimester abortions at Planned Parenthood clinics in the United States
in 2008
Some of the risks are:
• vaginal
bleeding or spotting
• cramps
• pelvic
pain
• vaginal
burning, itching, or discharge
• headache
• tiredness
• difficulty
falling asleep or staying asleep
• anxiety
No comments:
Post a Comment